(18:59 GMT) Immunovant Price Target Raised to $61.00/Share From $57.00 by Citigroup
Dow Jones Newswires
Immunovant Is Maintained at Buy by Citigroup
- Sources
- Dow Jones Newswires
- Markets
- Stocks
- Active symbols
- NASDAQ:IMVT
- Language
- English
(18:59 GMT) Immunovant Price Target Raised to $61.00/Share From $57.00 by Citigroup